| Tissue-restricted adaptive type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on group 2 innate lymphoid cells TYF Halim, BMJ Rana, JA Walker, B Kerscher, MD Knolle, HE Jolin, ... Immunity 48 (6), 1195-1207. e6, 2018 | 233 | 2018 |
| Brief report: group 3 innate lymphoid cells in human enthesis RJ Cuthbert, EM Fragkakis, R Dunsmuir, Z Li, M Coles, H Marzo‐Ortega, ... Arthritis & rheumatology 69 (9), 1816-1822, 2017 | 149 | 2017 |
| Epidermal Notch1 recruits RORγ+ group 3 innate lymphoid cells to orchestrate normal skin repair Z Li, T Hodgkinson, EJ Gothard, S Boroumand, R Lamb, I Cummins, ... Nature communications 7 (1), 11394, 2016 | 101 | 2016 |
| Anti-microbial functions of group 3 innate lymphoid cells in gut-associated lymphoid tissues are regulated by G-protein-coupled receptor 183 C Chu, S Moriyama, Z Li, L Zhou, AL Flamar, CSN Klose, JB Moeller, ... Cell reports 23 (13), 3750-3758, 2018 | 92 | 2018 |
| In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue Z Li, ZK Tuong, I Dean, C Willis, F Gaspal, R Fiancette, S Idris, B Kennedy, ... Journal of Experimental Medicine 219 (6), e20210749, 2022 | 79 | 2022 |
| A stromal cell niche for human and mouse type 3 innate lymphoid cells K Hoorweg, P Narang, Z Li, A Thuery, N Papazian, DR Withers, MC Coles, ... The Journal of Immunology 195 (9), 4257-4263, 2015 | 49 | 2015 |
| Integrin-alpha IIb identifies murine lymph node lymphatic endothelial cells responsive to RANKL OG Cordeiro, M Chypre, N Brouard, S Rauber, F Alloush, ... PLoS One 11 (3), e0151848, 2016 | 41 | 2016 |
| Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice S Wichaiyo, S Lax, SJ Montague, Z Li, B Grygielska, JA Pike, EJ Haining, ... Haematologica 104 (8), 1648, 2019 | 40 | 2019 |
| Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity I Dean, CYC Lee, ZK Tuong, Z Li, CA Tibbitt, C Willis, F Gaspal, ... Nature Communications 15 (1), 683, 2024 | 19 | 2024 |
| Quantitative methods for measuring repair rates and innate-immune cell responses in wounded mouse skin Z Li, E Gothard, MC Coles, CA Ambler Frontiers in immunology 9, 347, 2018 | 16 | 2018 |
| Inducible ablation of CD11c+ cells to determine their role in skin wound repair Z Li, R Lamb, MC Coles, CL Bennett, CA Ambler Immunology 163 (1), 105-111, 2021 | 14 | 2021 |
| Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity CYC Lee, BC Kennedy, N Richoz, I Dean, ZK Tuong, F Gaspal, Z Li, ... Nature Communications 15 (1), 682, 2024 | 5 | 2024 |
| Human enthesis group 3 innate lymphoid cells R Cuthbert, E Fragkakis, R Dunsmuir, Z Li, M Coles, H Marzo-Ortega, ... Arthritis Rheumatol 69 (9), 1816-1822, 2017 | 5 | 2017 |
| Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3 R Tachó-Piñot, CT Stamper, JI King, V Matei-Rascu, E Richardson, Z Li, ... Cell reports 42 (11), 2023 | 3 | 2023 |
| Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers I Dean, CYC Lee, ZK Tuong, Z Li, CA Tibbitt, C Willis, F Gaspal, ... bioRxiv, 2023.08. 10.552797, 2023 | 3 | 2023 |
| Notch in the epidermis: a damage sensor controlling immune responses in normal and pathological wound repair CA Ambler, MC Coles, Z Li, T Hodgkinson, EJ Gothard, A Bayat British Journal of Dermatology 175, 35-35, 2016 | 1 | 2016 |
| Protocol for transcutaneous tumor photolabeling to track immune cells in vivo using Kaede mice I Dean, BC Kennedy, Z Li, F Berditchevski, DR Withers STAR protocols 5 (2), 102956, 2024 | | 2024 |
| Inhibition of TNFalpha Release by Purine Nucleosides in a Human Monocyte-derived Microglial Model Exhibits Apparent Insensitivity to Adenosine, P2X, and P2Y Receptor Antagonism … O Qureshi, J Cowley, A Kaur, A Pegg, L Sallie, I Morano, N Harrison, ... Neurology 102 (17_supplement_1), 5885, 2024 | | 2024 |
| Dependence of human immune cell type, and impact of IL-7R or TLR1/2 agonism, upon trastuzumab-mediated ADCC M Bryant, G Tut, N Harrison, E Welsh, I Morano, A Kaur, A Pegg, H Chan, ... Cancer Research 84 (6_Supplement), 4045-4045, 2024 | | 2024 |
| Impact of IL-2 and IL-7 on human regulatory T cell suppression and pembrolizumab-mediated reversal of human T cell exhaustion G Tut, N Harrison, L Sallie, E Welsh, A Pegg, A Kaur, Z Li, I Morano, ... Cancer Research 84 (6_Supplement), 7540-7540, 2024 | | 2024 |
David WithersPrincipal Investigator, University of Birmingham在 bham.ac.uk 的电子邮件经过验证
